<?xml version="1.0" encoding="UTF-8"?>
<p>Compared with cis-MSM, transgender women were more likely to have been told they had HIV in the past (OR 2.78, 95% CI 2.03–3.81, 
 <italic>p &lt;</italic> 0.001) and to have tested positive on the rapid HIV test conducted during the study (25% versus 14%; OR 1.81, 95% CI 1.49–2.19, 
 <italic>p &lt;</italic> 0.001) (
 <xref ref-type="table" rid="pmed.1002422.t004">Table 4</xref>). As expected, HIV prevalence varied widely by country (
 <xref ref-type="table" rid="pmed.1002422.t005">Table 5</xref>). In 4 of the 8 countries (Côte d’Ivoire, Lesotho, Senegal, and Togo), transgender women had significantly higher HIV prevalence than cis-MSM, and, in the remainder, there was no statistically significant difference by gender. HIV prevalence was highest in Lesotho, at 59% among transgender women compared with 29% among cis-MSM (OR 3.63, 95% CI 2.17–6.17, 
 <italic>p &lt;</italic> 0.001).
</p>
